Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Yuanjue Zhu"'
Autor:
Yuanjue Zhu1, Yong Liu1, Weixun Zhou2, Ruolan Xiang3, Lei Jiang1, Kewu Huang4, Yu Xiao2, Zijian Guo1, Jinming Gao1 gaojm@pumch.cn
Publikováno v:
Respiratory Research. 2010, Vol. 11, p34-45. 12p.
Autor:
Shunwei Li, Karel P. Van de Woestijne, Yuanjue Zhu, Jian Zhang, Orner Van Den Bergh, Jiangna Han, Xiansheng Cheng
Publikováno v:
Chest. 133:961-968
Medically unexplained dyspnea (MUD) refers to a condition characterized by a sensation of dyspnea and is typically applied to patients presenting with anxiety and hyperventilation without cardiopulmonary explanations for their dyspnea. The diagnosis
Autor:
Omer Van den Bergh, DM Luo, Ilse Van Diest, Karel P. Van de Woestijne, Jiangna Han, Yuanjue Zhu, Shunwei Li
Publikováno v:
Chinese Medical Journal. 121:56-62
BACKGROUND Medically unexplained dyspnea refers to a condition characterized by a sensation of dyspnea and is typically applied to patients presenting with anxiety and hyperventilation without underlying cardiopulmonary pathology. We were interested
Autor:
Karel P. Van de Woestijne, Shunwei Li, Omer Van den Bergh, Yuanjue Zhu, Jiangna Han, Claudia Put, Xiansheng Chen
Publikováno v:
Chest. 127:1942-1951
Study objectives We investigated the qualitative components of a wide range of Chinese descriptors of dyspnea and associated symptoms, and their relevance for clinical diagnosis. Measurements Sixty-one spontaneously reported descriptors were elicited
Autor:
Mona Palmqvist, Eric D. Bateman, Yuanjue Zhu, Hans Bisgaard, Massimo Pistolesi, Philippe Godard, Paul M. O'Byrne, Tommy Ekström
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 171:129-136
Asthma control is improved by combining inhaled corticosteroids with long-acting beta2-agonists. However, fluctuating asthma control still occurs. We hypothesized that in patients receiving low maintenance dose budesonide/formoterol (bud/form), repla
Autor:
Zi-jian Guo, Lei Jiang, Jinming Gao, Ruolan Xiang, Kewu Huang, Yuanjue Zhu, Yu Pei Xiao, Weixun Zhou, Yong X Liu
Publikováno v:
Respiratory Research, Vol 11, Iss 1, p 34 (2010)
Respiratory Research
Respiratory Research
Background Metabolites of arachidonic acid such as prostacyclin (PGI2) have been shown to participate in the pathogenesis of pulmonary fibrosis by inhibiting the expression of pro-inflammatory and pro-fibrotic mediators. In this investigation, we exa
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 46(10)
The current asthma guidelines encourage use of a diary for assessing and monitoring symptoms and airway function. However, patient compliance and acceptability are usually poor owing to the burden of frequent and prolonged assessment.We investigated
Autor:
Walter Canonica, Andrea Morris, Klaus F. Rabe, Neil Schachter, Nicholas Locantore, Stephen I. Rennard, Yuanjue Zhu, Katharine Knobil, Frank Barnhart
Publikováno v:
Drugs. 68
The aim of this review is to present the clinical data on the efficacy and safety of cilomilast in patients with chronic obstructive pulmonary disease (COPD). Over 6000 COPD patients received cilomilast during an extensive clinical development progra
Publikováno v:
Respirology (Carlton, Vic.). 13(4)
Background and objective It has been suggested that the rapid increase in asthma prevalence may in part be due to a decrease in the intake of dietary antioxidants, including vitamin C, vitamin E and beta-carotene. Epidemiological studies investigatin
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 313(1)
The potential role of PFD [5-methyl-L-phenyl-2-(1H)-pyridone], an antifibrotic compound with anti-inflammatory effects, in several models of acute lung injury (ALI) has gained increasing attention; however, the protective effect of PFD in oleic acid